News

FinSMEs Exclusive Interview with GAP Funds VP and MD Tom Weithman

FinSMEs Exclusive Interview with GAP Funds VP and MD Tom Weithman

CIT GAP Funds Portfolio Reaches New 100 Milestone with Investment in Neoantigenics

CIT announced today that its CIT GAP Funds’ portfolio reached 100 companies with an investment in Neoantigenics, a University of Virginia spin-out and...

Natural Insight Unveils Major Upgrades at 3rd Annual User Conference

CIT GAP Portfolio Company - Natural Insight, a leading provider of cloud based workforce management software to merchandisers, product companies, event...

CIT Entrepreneur

CIT recognizes that the availability of early-stage capital is a critical need of many emerging technology companies by making connection with “hard to access” private and federal funding sources.

  • GAP Funds – CIT GAP Funds makes seed-stage equity investments in Virginia-based technology and life science companies with a high potential for achieving rapid growth and generating significant economic return.  Click here for more information on CIT GAP Funds.

 

  • Federal Funding Assistance Program – CIT's Federal Funding Assistance Program identifies and accelerates opportunities for Virginia's small technology businesses to obtain SBIR, STTR and ATP awards and other government contracts. Click here for additional information about the Federal Funding Assistance Program.